Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
LOUISVILLE, Ky., Feb. 22, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the Texas State Board of Pharmacy (TSBP) has signed an agreement to adopt Appriss' Prescription Drug Monitoring Solution, PMP AWARxE, to improve patient safety, combat prescription drug abuse and drug diversion.
Prescription Monitoring Programs (PMPs) are state-run programs that track the distribution of narcotics and other prescriptions for federally controlled substances. PMP AWARxE provides access to mandatory pharmacy reporting and offers secure accessibility to data across state lines.
"Appriss is proud to support the TSBP in the promotion of patient safety," said Krishnan Sastry, Executive Vice President of Appriss. "There is a definite evolution of focus of the prescription monitoring programs from solely being a vehicle for surveillance and law enforcement to one that helps identify patients at risk for opioid abuse and finding them the help they need. PMPs can serve as a core foundation in that mission to improve patient safety and fight addiction."
The TSBP will implement the HIPAA-compliant PMP platform in the fall of 2016 and joins 24 other states in adopting an Appriss prescription monitoring solution nationally.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]
